Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi
Authors:
- Aura CalderaACAura Caldera
- Maria de Nazareth L. MeirellesMMMaria de Nazareth L. Meirelles
- Solange L.DE CastroSCSolange L.DE Castro
- Roberto DocampoRDRoberto Docampo
- Gary A. MeintsGMGary A. Meints
- Eric OldfieldEOEric Oldfield
- Julio A. UrbinaJUJulio A. Urbina
- 1 March 2004
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 23 (3) , 273-285
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Chemotherapy of Chagas DiseaseCurrent Pharmaceutical Design, 2002
- A Critical Review on Chagas Disease ChemotherapyMemórias do Instituto Oswaldo Cruz, 2002
- Specific Molecular Targets to Control Tropical DiseasesCurrent Pharmaceutical Design, 2001
- Recent Developments in the Chemotherapy of Chagas DiseaseCurrent Pharmaceutical Design, 2001
- The Intracellular Target for the Antiresorptive Aminobisphosphonate Drugs in Dictyostelium discoideum Is the Enzyme Farnesyl Diphosphate SynthaseJournal of Bone and Mineral Research, 2000
- Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate SynthaseArchives of Biochemistry and Biophysics, 2000
- Farnesyl Pyrophosphate Synthase Is the Molecular Target of Nitrogen-Containing BisphosphonatesBiochemical and Biophysical Research Communications, 1999
- Nitrogen-Containing Bisphosphonates as Carbocation Transition State Analogs for Isoprenoid BiosynthesisBiochemical and Biophysical Research Communications, 1999
- The Discovery of a Novel Site of Action for Herbicidal BisphosphonatesPesticide Biochemistry and Physiology, 1999
- Nitrogen-Containing Bisphosphonates Inhibit Isopentenyl Pyrophosphate Isomerase/Farnesyl Pyrophosphate Synthase Activity with Relative Potencies Corresponding to Their Antiresorptive Potenciesin Vitroandin VivoBiochemical and Biophysical Research Communications, 1999